Companies › Guangzhou Gloria Biosciences
3 active drug programs in 8 registered trials: 3 Phase 1, 2 Phase 3, 2 Phase 2, 1 Phase 4; Oncology, Hematology; next expected readout Dec 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Zimberelimab (GLS-010) Programmed cell death protein 1 inhibitor | PDCD1 | Phase 3 | Persistent, Recurrent, or Metastatic Cervical Cancer; Solid Tumor | Dec 2026 |
| Motixafortide (BL-8040) C-X-C chemokine receptor type 4 antagonist | CXCR4 | Phase 3 | Multiple Myeloma; Pancreatic Cancer; Acute Myeloid Leukemia; Sickle Cell Disease | May 2027 |
| GLS-012 | – | Phase 1 | Solid Tumor | Dec 2026 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT05909436 | GLS-012 | Phase 1 | Solid Tumor | Oncology | Dec 2026 |
| NCT05909436 | Zimberelimab (GLS-010) | Phase 1 | Solid Tumor | Oncology | Dec 2026 |
| NCT07101445 | Motixafortide (BL-8040) | Phase 4 | Multiple Myeloma | Oncology | Dec 2026 |
| NCT06514508 | Motixafortide (BL-8040) | Phase 3 | Multiple Myeloma | Oncology | May 2027 |
| NCT06442761 | Motixafortide (BL-8040) | Phase 1 | Sickle Cell Disease | Hematology | Jan 2028 |
| NCT04543071 | Motixafortide (BL-8040) | Phase 2 | Pancreatic Cancer | Oncology | Jun 2028 |
| NCT07392970 | Motixafortide (BL-8040) | Phase 2 | Acute Myeloid Leukemia | Oncology | Aug 2028 |
| NCT05798819 | Zimberelimab (GLS-010) | Phase 3 | Persistent, Recurrent, or Metastatic Cervical Cancer | Oncology | Dec 2029 |
Binhui Biopharmaceutical TaiRx Evopoint Biosciences CStone Pharmaceuticals Dizal Pharmaceuticals
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.